Prithviraj Bose
M.D. Anderson Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Prithviraj Bose as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:12 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04517851 · Elotuzumab for the Treatment of JAK2-Mutated MyelofibrosisM.D. Anderson Cancer Center · active not recruiting · Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis · principal investigator
- Ph2NCT03019939 · Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and NeutropeniaM.D. Anderson Cancer Center · completed · Acute Myeloid Leukemia, Myelodysplastic Syndrome, Neutropenia · principal investigator
- Ph2/Ph3NCT02801578 · A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)M.D. Anderson Cancer Center · completed · Chronic Lymphocytic Leukemia · principal investigator
- Ph2NCT02784496 · Long-Term Side Effects of Ruxolitinib in Treating Patients With MyelofibrosisM.D. Anderson Cancer Center · completed · Myelofibrosis · principal investigator
- Ph1NCT02782403 · Axitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid LeukemiaM.D. Anderson Cancer Center · terminated · Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase Chronic Myelogenous Leukemia (CML) · principal investigator
- Ph2NCT01712308 · Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or AnemiaM.D. Anderson Cancer Center · completed · Anemia, Myelodysplastic/Myeloproliferative Neoplasm, Myelofibrosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in chronic myeloid leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 10:12 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed